Literature DB >> 33568070

Enhancer RNAs: transcriptional regulators and workmates of NamiRNAs in myogenesis.

Emmanuel Odame1, Yuan Chen1, Shuailong Zheng1, Dinghui Dai1, Bismark Kyei1, Siyuan Zhan1, Jiaxue Cao1, Jiazhong Guo1, Tao Zhong1, Linjie Wang1, Li Li2, Hongping Zhang3.   

Abstract

miRNAs are well known to be gene repressors. A newly identified class of miRNAs termed nuclear activating miRNAs (NamiRNAs), transcribed from miRNA loci that exhibit enhancer features, promote gene expression via binding to the promoter and enhancer marker regions of the target genes. Meanwhile, activated enhancers produce endogenous non-coding RNAs (named enhancer RNAs, eRNAs) to activate gene expression. During chromatin looping, transcribed eRNAs interact with NamiRNAs through enhancer-promoter interaction to perform similar functions. Here, we review the functional differences and similarities between eRNAs and NamiRNAs in myogenesis and disease. We also propose models demonstrating their mutual mechanism and function. We conclude that eRNAs are active molecules, transcriptional regulators, and partners of NamiRNAs, rather than mere RNAs produced during enhancer activation.

Entities:  

Keywords:  Enhancer RNA; MicroRNA; Myogenesis; NamiRNAs; Transcriptional regulator

Year:  2021        PMID: 33568070      PMCID: PMC7877072          DOI: 10.1186/s11658-021-00248-x

Source DB:  PubMed          Journal:  Cell Mol Biol Lett        ISSN: 1425-8153            Impact factor:   5.787


  109 in total

1.  miRNA-Mediated RNAa by Targeting Enhancers.

Authors:  Qingping Zou; Ying Liang; Huaibing Luo; Wenqiang Yu
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

2.  eRNAs are required for p53-dependent enhancer activity and gene transcription.

Authors:  Carlos A Melo; Jarno Drost; Patrick J Wijchers; Harmen van de Werken; Elzo de Wit; Joachim A F Oude Vrielink; Ran Elkon; Sónia A Melo; Nicolas Léveillé; Raghu Kalluri; Wouter de Laat; Reuven Agami
Journal:  Mol Cell       Date:  2012-12-27       Impact factor: 17.970

3.  Super-Enhancer-Mediated RNA Processing Revealed by Integrative MicroRNA Network Analysis.

Authors:  Hiroshi I Suzuki; Richard A Young; Phillip A Sharp
Journal:  Cell       Date:  2017-03-09       Impact factor: 41.582

4.  Enhancer RNAs participate in androgen receptor-driven looping that selectively enhances gene activation.

Authors:  Chen-Lin Hsieh; Teng Fei; Yiwen Chen; Tiantian Li; Yanfei Gao; Xiaodong Wang; Tong Sun; Christopher J Sweeney; Gwo-Shu Mary Lee; Shaoyong Chen; Steven P Balk; Xiaole Shirley Liu; Myles Brown; Philip W Kantoff
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-28       Impact factor: 11.205

5.  MicroRNA-10a binds the 5'UTR of ribosomal protein mRNAs and enhances their translation.

Authors:  Ulf Andersson Ørom; Finn Cilius Nielsen; Anders H Lund
Journal:  Mol Cell       Date:  2008-05-23       Impact factor: 17.970

6.  Human Argonaute 2 Is Tethered to Ribosomal RNA through MicroRNA Interactions.

Authors:  Blake L Atwood; Jessica L Woolnough; Gaelle M Lefevre; Mariana Saint Just Ribeiro; Gary Felsenfeld; Keith E Giles
Journal:  J Biol Chem       Date:  2016-06-10       Impact factor: 5.157

7.  Intragenic Enhancers Attenuate Host Gene Expression.

Authors:  Senthilkumar Cinghu; Pengyi Yang; Justin P Kosak; Amanda E Conway; Dhirendra Kumar; Andrew J Oldfield; Karen Adelman; Raja Jothi
Journal:  Mol Cell       Date:  2017-10-05       Impact factor: 17.970

8.  RNAi factors are present and active in human cell nuclei.

Authors:  Keith T Gagnon; Liande Li; Yongjun Chu; Bethany A Janowski; David R Corey
Journal:  Cell Rep       Date:  2014-01-02       Impact factor: 9.423

Review 9.  Enhancer RNAs (eRNAs): New Insights into Gene Transcription and Disease Treatment.

Authors:  Mengting Ding; Yuhan Liu; Xinhui Liao; Hengji Zhan; Yuchen Liu; Weiren Huang
Journal:  J Cancer       Date:  2018-06-06       Impact factor: 4.207

10.  The enhancer RNA lnc-SLC4A1-1 epigenetically regulates unexplained recurrent pregnancy loss (URPL) by activating CXCL8 and NF-kB pathway.

Authors:  Zhenyao Huang; Guizhen Du; Xiaomin Huang; Li Han; Xiumei Han; Bo Xu; Yan Zhang; Mingming Yu; Yufeng Qin; Yankai Xia; Xinru Wang; Chuncheng Lu
Journal:  EBioMedicine       Date:  2018-11-16       Impact factor: 8.143

View more
  1 in total

1.  Deciphering the Molecular Mechanism of Incurable Muscle Disease by a Novel Method for the Interpretation of miRNA Dysregulation.

Authors:  David Israeli; Ai Vu Hong; Guillaume Corre; Quentin Miagoux; Isabelle Richard
Journal:  Noncoding RNA       Date:  2022-06-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.